This retrospective analysis used the Pediatric Health Information System administrative database to identify cases of renal vein thrombosis in patients younger than 18 years. The authors excluded instances attributable to tumor thrombus to focus on thrombotic disease. In total, 383 eligible cases were identified and followed for a combined 796 patient-years. The cohort included a substantial neonatal component: 48.8% of cases occurred in neonates (≤28 days).
Among the 383 cases, 25.3% occurred in children with pre-existing complex chronic conditions. A smaller but notable subset (9.1%) presented in association with the onset of nephrotic syndrome. The report documents an overall mortality of 15.1% following the index renal vein thrombosis event, but emphasizes that causality for deaths cannot be determined from administrative data.
Most patients in this series were treated with anticoagulation—80.2% of cases received anticoagulant therapy. The remaining proportion of patients did not receive anticoagulation, but the authors note that the relatively low percentage of non-anticoagulated patients limits causal inference and raises concerns about treatment selection bias in observational administrative data.
Survivors of pediatric renal vein thrombosis experienced substantial rates of adverse renal outcomes during follow-up. The analysis reports the following prevalences across the cohort:
The investigators assessed whether anticoagulation influenced the likelihood of these long-term renal sequelae and did not detect a discernable protective effect of anticoagulant treatment in this dataset. The authors caution that the small non-anticoagulated group and potential treatment bias limit the strength of conclusions about anticoagulation effectiveness for preventing long-term kidney outcomes.
The study included planned sub-analyses comparing neonatal (≤28 days) and non-neonatal renal vein thrombosis to explore differences in presentation and outcomes. The abstract reports that 48.8% of cases were neonatal, and that subgroup comparisons were performed, but detailed numerical breakdowns of outcomes by neonatal status and the results of those subgroup comparisons are not provided in the abstract. The full manuscript and supplementary material are noted as available for additional data.
Several limitations inherent to administrative database research are acknowledged or implied by the methods and findings. Key limitations include the inability to assign causality for mortality, potential misclassification of diagnoses and outcomes within administrative coding, and confounding by indication—particularly for anticoagulation practice. The high rate of anticoagulation use (80.2%) and the relatively small comparator group of non-anticoagulated patients make it difficult to determine whether anticoagulation changes long-term renal risk.
The authors therefore interpret their primary findings conservatively: AKI, CKD, and hypertension are prevalent among survivors of pediatric renal vein thrombosis, and no clear association between anticoagulation and reduced long-term renal adverse outcomes was observed in this dataset.
Given the documented prevalences of AKI, CKD, and hypertension after pediatric renal vein thrombosis, the authors recommend longitudinal surveillance of kidney health in survivors. They highlight the need for further research to clarify whether anticoagulation or other interventions can modify long-term renal risk, ideally using study designs that mitigate treatment selection bias and allow causal inference.
The study is a preprint and has not undergone peer review; the authors explicitly state that it should not be used to guide clinical practice without validation. Funding sources and competing interest disclosures are provided in the manuscript: the work received support from the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK124549) and other foundations; several authors disclosed external consulting or research relationships. The IRB of Nationwide Children’s Hospital waived ethical approval for this analysis. All data produced are reported as contained within the manuscript or supplementary material.